| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 8 | 7 | 7 | 7 | 9 | 15 | 14 | 14 | 12 | 16 | 15 | 18 |
| Expenses | 7 | 7 | 6 | 6 | 9 | 14 | 13 | 13 | 11 | 14 | 14 | 16 |
| EBITDA | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Operating Profit % | 4 % | 4 % | 6 % | 7 % | 6 % | 5 % | 7 % | 8 % | 6 % | 6 % | 7 % | 7 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS in ₹ | 0.74 | 0.46 | 0.61 | 0.83 | 1.18 | 1.83 | 2.77 | 2.69 | 1.93 | 2.50 | 2.90 | 3.20 |
Ishita Drugs & Indus
Ishita Drugs & Indus
72.00
+1.99
(2.84%)
There are 2 new updates from the company22 hours ago
View
Key Fundamentals
Market Cap
21.49 Cr
EPS
2.90
PE Ratio
21.54
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
99.64
52 Week Low
62.35
PB Ratio
1.86
Debt to Equity
0.19
Sector
Pharmaceuticals Actual
Company News
View All News
Ishita Pharmaceuticals Acquires Additional Shares in Ishita Drugs Industries22 hours ago
Ishita Pharmaceuticals, a related party of Ishita Drugs Industries Limited, acquired 114 shares of Rs. 10 each through open market purchase on November 19, 2025. The acquisition increased their total holding to 26,399 shares, maintaining their 0.88% stake in the target company's equity share capital of Rs. 2.99 crore.
Ishita Drugs Industries Reports Quarterly Results and Manufacturing Facility Upgrade Progress
9 days ago
9 days agoIshita Drugs Industries Limited's Board of Directors approved unaudited financial results for the quarter and half year ended September 30, 2025. The company reported revenue from operations of Rs. 806.81 lakhs for the quarter and Rs. 1499.73 lakhs for the half year. Net profit for the quarter was Rs. 14.33 lakhs compared to Rs. 30.23 lakhs in the previous quarter. The Board discussed the manufacturing facility upgradation project for compliance with Revised Schedule M. A civil contractor has been appointed and construction has commenced, though progress was affected by higher-than-normal rainfall and extended monsoon period. The company has incurred expenditure of nearly Rs. 50 lakhs toward civil construction of this project. Basic earnings per share from continuing operations was Rs. 0.48 for the quarter.
Ishita Drugs & Industries Passes All 7 Resolutions at 32nd AGMOct 01, 2025
Ishita Drugs & Industries Limited held its 32nd Annual General Meeting on September 29, 2025, where all seven proposed resolutions were passed with requisite majority. The approved items included adoption of audited financial statements for the year ended March 31, 2025, re-appointment of Mrs. Abha Agrawal as director, appointment of statutory auditor for 2025-26, re-appointment of Mr. Arvind Vilasrao Sapkal as Non-executive Independent Director, appointment of M/s Meenu Maheshwari & Associates as Secretarial Auditor, and approval of related party transactions with Ishita Pharmaceuticals and Anvi Lifesciences Private Limited. The meeting had 45 shareholders participating, representing 1,558,051 shares. All resolutions received 100% votes in favor with no votes against.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,781.70 | #1 4,27,489.51 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,391.50 | 1,69,674.24 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,688.60 | 1,24,838.98 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.20 | 1,22,552.45 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,247.40 | 1,04,109.72 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.05 | 93,182.30 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.40 | 92,830.79 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,241.80 | 92,532.20 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,209.80 | 70,265.38 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,692.50 | 68,062.38 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
-1.29 %
Net Income Growth
28.57 %
Cash Flow Change
-271.70 %
ROE
6.76 %
ROCE
4.06 %
EBITDA Margin (Avg.)
13.54 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 7 | 8 | 7 | 7 | 8 | 10 | 9 | 11 | 11 | 11 | 16 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Current Assets | 6 | 7 | 6 | 6 | 7 | 8 | 8 | 10 | 10 | 10 | 15 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 2 | 3 | 3 | 4 | 5 | 3 | 4 | 3 | 3 | 4 |
| Other Assets | 4 | 5 | 4 | 3 | 3 | 3 | 5 | 6 | 7 | 7 | 12 |
| Total Liabilities | 7 | 8 | 7 | 7 | 8 | 10 | 9 | 11 | 11 | 11 | 16 |
| Current Liabilities | 1 | 3 | 1 | 1 | 2 | 3 | 1 | 3 | 2 | 1 | 5 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 6 | 6 | 6 | 6 | 6 | 7 | 8 | 9 | 9 | 10 | 11 |
| Reserve & Surplus | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 6 | 6 | 7 | 8 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 1 | -1 | 0 | -0 | 0 | 2 | 2 | -1 | 1 | 0 |
| Investing Activities | -0 | -0 | -1 | -1 | -1 | -1 | 3 | -1 | 1 | 0 | -1 |
| Operating Activities | 0 | 0 | 1 | 1 | 1 | 1 | -1 | 3 | -3 | 2 | -4 |
| Financing Activities | -0 | 1 | -1 | 0 | 0 | 0 | -0 | 0 | 1 | -1 | 4 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 47.87 % | 47.87 % | 47.87 % | 48.37 % | 49.31 % | 49.32 % | 49.32 % | 49.32 % | 49.38 % | 49.38 % | 49.38 % | 49.38 % | 49.42 % | 49.80 % | 49.80 % | 49.85 % | 49.91 % | 49.92 % | 49.96 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.38 % | 0.38 % | 0.38 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 45.48 % | 45.16 % | 43.47 % | 43.74 % | 44.00 % | 44.05 % | 43.59 % | 44.24 % | 44.17 % | 44.11 % | 46.07 % | 47.04 % | 47.48 % | 47.51 % | 47.17 % | 46.89 % | 46.89 % | 46.76 % | 46.63 % |
| Others | 6.65 % | 6.97 % | 8.66 % | 7.88 % | 6.69 % | 6.63 % | 6.71 % | 6.06 % | 6.06 % | 6.51 % | 4.55 % | 3.58 % | 3.09 % | 2.69 % | 3.03 % | 3.27 % | 3.20 % | 3.33 % | 3.42 % |
| No of Share Holders | 0 | 4,425 | 4,455 | 4,787 | 4,814 | 4,847 | 4,972 | 4,944 | 4,899 | 5,033 | 5,134 | 5,283 | 5,351 | 5,272 | 5,555 | 5,412 | 5,398 | 5,341 | 5,320 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 82.61 | 79.95 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 77.96 | 78.98 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 85.57 | 75.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 77.45 | 75.17 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 78.00 | 70.75 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 75.10 | 81.60 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 70.80 | 70.52 |
Announcements
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 201122 hours ago
22 hours ago Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 201122 hours ago
22 hours agoDisclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 20111 day ago
1 day agoOutcome Of Board Meeting Held On 11Th November 20259 days ago
9 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 11Th November 20259 days ago
9 days agoBoard Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 30Th September 2025Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Sep 17, 2025
Sep 17, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Sep 05, 2025
Sep 05, 2025 Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025NOTICE OF 32ND ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIODSep 02, 2025
Sep 02, 2025INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION 2015Aug 30, 2025
Aug 30, 2025NTIMATION ABOUT THE BOOK CLOSURE FOR 32ND ANNUAL GENERAL MEETING (AGM)Aug 30, 2025
Aug 30, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Aug 28, 2025
Aug 28, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Aug 12, 2025Outcome Of Board Meeting Held On 12Th August 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2025Aug 12, 2025
Aug 12, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 30Th June 2025Aug 06, 2025
Aug 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Jun 25, 2025
Jun 25, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 - Update On Current Business Operations Of The CompanyJun 13, 2025
Jun 13, 2025Board Meeting Outcome for Outcome - Update On Current Business Operations Of The CompanyJun 13, 2025
Jun 13, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015Jun 10, 2025
Jun 10, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Outcome Of Board Meeting Held On 30Th May 2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2025May 30, 2025
May 30, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations 2015 For The Quarter And Year Ended 31St March 2025May 23, 2025
May 23, 2025Non Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 14, 2025
May 14, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 25, 2025
Apr 25, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Apr 23, 2025Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2025Apr 14, 2025
Apr 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Apr 09, 2025Closure of Trading WindowMar 19, 2025
Mar 19, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Mar 01, 2025
Mar 01, 2025Integrated Filing (Financial)Feb 13, 2025
Feb 13, 2025Outcome Of Board Meeting Held On 13Th February 2025Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2025Feb 13, 2025
Feb 13, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 20Feb 06, 2025
Feb 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Jan 13, 2025Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011Dec 31, 2024
Dec 31, 2024Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Dec 28, 2024
Dec 28, 2024Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Dec 28, 2024
Dec 28, 2024Technical Indicators
RSI(14)
Neutral 42.84
ATR(14)
Less Volatile 2.48
STOCH(9,6)
Neutral 53.97
STOCH RSI(14)
Neutral 45.47
MACD(12,26)
Bullish 0.06
ADX(14)
Weak Trend 8.25
UO(9)
Bearish 50.15
ROC(12)
Downtrend And Accelerating -4.08
WillR(14)
Neutral -70.95
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
